Insmed names Will Lewis CEO and President effective immediately Lewis succeeds Tim Whitten, who resigned as President and CEO of the company. Whitten was most recently the CFO of Aegerion Pharmaceuticals. The company also appointed Donald Hayden as chairman of the board.
News For INSM From The Last 14 Days
Check below for free stories on INSM the last two weeks.